Zheng Y, Yu K, Lin J, Liang Z, Zhang Q, Li J
Nat Commun. 2025; 16(1):2511.
PMID: 40087285
DOI: 10.1038/s41467-025-57858-8.
Deng Y, Hou M, Wu Y, Liu Y, Xia X, Yu C
Bone Res. 2025; 13(1):36.
PMID: 40087281
DOI: 10.1038/s41413-025-00413-4.
Hu C, Chen Y, Yin X, Xu R, Yin C, Wang C
Signal Transduct Target Ther. 2025; 10(1):39.
PMID: 39948335
PMC: 11825823.
DOI: 10.1038/s41392-024-02098-3.
Qian X, Zhou Q, Ouyang Y, Wu X, Sun X, Wang S
Proc Natl Acad Sci U S A. 2025; 122(5):e2412473122.
PMID: 39888917
PMC: 11804496.
DOI: 10.1073/pnas.2412473122.
Luo S, Jiang X, Lu Z
Life Metab. 2025; 1(3):205-206.
PMID: 39872073
PMC: 11748969.
DOI: 10.1093/lifemeta/loac022.
The Impact of Metabolic Rewiring in Glioblastoma: The Immune Landscape and Therapeutic Strategies.
Vijayanathan Y, Ho I
Int J Mol Sci. 2025; 26(2).
PMID: 39859381
PMC: 11765942.
DOI: 10.3390/ijms26020669.
HACD2 Promotes Pancreatic Cancer Progression by Enhancing PKM2 Dissociation From PRKN in a Dehydratase-Independent Manner.
Chu X, Zhao J, Shen Y, Feng Q, Zhou C, Ma L
Adv Sci (Weinh). 2025; 12(10):e2407942.
PMID: 39836601
PMC: 11904967.
DOI: 10.1002/advs.202407942.
ERK-USP9X-coupled regulation of thymidine kinase 1 promotes both its enzyme activity-dependent and its enzyme activity-independent functions for tumor growth.
Tao J, Wang Z, Shi R, Lin L, Li M, Meng Y
Nat Struct Mol Biol. 2025; .
PMID: 39824978
DOI: 10.1038/s41594-024-01473-6.
Nucleus-translocated GCLM promotes chemoresistance in colorectal cancer through a moonlighting function.
Lin J, Liu Z, Chen D, Huang R, Cao F, Yu K
Nat Commun. 2025; 16(1):263.
PMID: 39747101
PMC: 11696352.
DOI: 10.1038/s41467-024-55568-1.
TIPE drives a cancer stem-like phenotype by promoting glycolysis via PKM2/HIF-1α axis in melanoma.
Tian M, Yang L, Zhao Z, Li J, Wang L, Yin Q
Elife. 2024; 13.
PMID: 39728923
PMC: 11677236.
DOI: 10.7554/eLife.92741.
Atorvastatin inhibits glioma glycolysis and immune escape by modulating the miR-125a-5p/TXLNA axis.
Gao K, Zhou T, Yin Y, Sun X, Jiang H, Li T
Hereditas. 2024; 161(1):54.
PMID: 39726023
PMC: 11670371.
DOI: 10.1186/s41065-024-00349-5.
Ubiquitin-specific protease 7 maintains c-Myc stability to support pancreatic cancer glycolysis and tumor growth.
Gu J, Xiao X, Zou C, Mao Y, Jin C, Fu D
J Transl Med. 2024; 22(1):1135.
PMID: 39707401
PMC: 11662425.
DOI: 10.1186/s12967-024-05962-6.
Comparative analysis of PI3K-AKT and MEK-ERK1/2 signaling-driven molecular changes in granulosa cells.
Baddela V, Michaelis M, Tao X, Koczan D, Brenmoehl J, Vanselow J
Reproduction. 2024; 169(2).
PMID: 39665647
PMC: 11774274.
DOI: 10.1530/REP-24-0317.
Metabolic imaging distinguishes ovarian cancer subtypes and detects their early and variable responses to treatment.
Chia M, Bulat F, Gaunt A, Ros S, Wright A, Sawle A
Oncogene. 2024; 44(9):563-574.
PMID: 39639170
PMC: 11850285.
DOI: 10.1038/s41388-024-03231-w.
Podocyte SIRPα reduction in diabetic nephropathy aggravates podocyte injury by promoting pyruvate kinase M2 nuclear translocation.
Chen Y, Zhang M, Jia R, Qian B, Jing C, Zeng C
Redox Biol. 2024; 78:103439.
PMID: 39586122
PMC: 11625355.
DOI: 10.1016/j.redox.2024.103439.
Pan-ErbB inhibition impairs cognition via disrupting myelination and aerobic glycolysis in oligodendrocytes.
Hu X, Zhu Q, Lou T, Hu Q, Li H, Xu Y
Proc Natl Acad Sci U S A. 2024; 121(45):e2405152121.
PMID: 39475641
PMC: 11551437.
DOI: 10.1073/pnas.2405152121.
Non-metabolic enzyme function of pyruvate kinase M2 in breast cancer.
Jemal M, Getinet M, Amare G, Tegegne B, Baylie T, Mengistu E
Front Oncol. 2024; 14:1450325.
PMID: 39411137
PMC: 11473492.
DOI: 10.3389/fonc.2024.1450325.
Berberine Targets PKM2 to Activate the t-PA-Induced Fibrinolytic System and Improves Thrombosis.
Sun Z, Zhao T, Bai X, Li H, Gao J, Hao Y
Pharmaceuticals (Basel). 2024; 17(9).
PMID: 39338381
PMC: 11434879.
DOI: 10.3390/ph17091219.
PAK5-mediated PKM2 phosphorylation is critical for anaerobic glycolysis in endometriosis.
Lu J, Wang X, Shi X, Jiang J, Liu L, Liu L
Front Med. 2024; 18(6):1054-1067.
PMID: 39331255
DOI: 10.1007/s11684-024-1069-3.
Unraveling the Mystery of Energy-Sensing Enzymes and Signaling Pathways in Tumorigenesis and Their Potential as Therapeutic Targets for Cancer.
Mirza Z, Karim S
Cells. 2024; 13(17.
PMID: 39273044
PMC: 11394487.
DOI: 10.3390/cells13171474.